Advertisement

Topics

Alzheimer’s Australia Company Profile

05:50 EST 17th December 2018 | BioPortfolio

Dr Tanya Petrovich, Business Development Manager, Alzheimer’s Australia Vic;


News Articles [1490 Associated News Articles listed on BioPortfolio]

Breakthrough drug could slow progress of Alzheimer’s disease – Starts at 60

Starts at 60Breakthrough drug could slow progress of Alzheimer's diseaseStarts at 60A new drug could change the way Alzheimer's disease is treated in the future. Source: Getty. Alzheimer's is one of t...

Greg Kennedy honored with 2018 Alzheimer Award

(IOS Press) Amsterdam, NL, July 16, 2018 -- The Journal of Alzheimer's Disease (JAD) is pleased to announce that Greg Kennedy, a PhD candidate at the Centre for Human Psychopharmacology, Swinburne Uni...

Discovery presents treatment hope for Alzheimer's and other neurodegenerative diseases

(University of South Australia) There is new hope for the treatment of Alzheimer's and other neurological diseases following a ground-breaking discovery made by an Australian-Chinese research collabor...

How An Alzheimer Treatment's Success Highlights The Failures In Alzheimer's Drug Research

How the takeover of a biotech company with a late stage Alzheimer's Drug highlights the lack of any other success in the fight against Alzheimer's. And how we must look at new ways to advance research...

Alzheimer Disease | Medscape

Review in-depth clinical information, latest medical news, and guidelines on Alzheimer Disease. Recognize the causes of Alzheimer Disease and signs of Alzheimer Disease, including dementia.

Health Tip: 10 Signs of Alzheimer's

-- Nearly 50 million people worldwide are living with Alzheimer's disease and other forms of dementia, the Alzheimer's Association says. The association lists 10 warnings signs of Alzheimer's: Memory...

Never-before-seen DNA recombination in the brain linked to Alzheimer's disease

Scientists have identified gene recombination in neurons that produces thousands of new gene variants within Alzheimer's disease brains. The study reveals for the first time how the Alzheimer's-linked...

Classifying Alzheimer's patients in 6 subgroups

Researchers studying Alzheimer's disease have created an approach to classify patients with Alzheimer's disease, a finding that may open the door for personalized treatments. "Alzheimer's, like breas...

PubMed Articles [1219 Associated PubMed Articles listed on BioPortfolio]

Is the risk of developing Alzheimer's disease really higher in rural areas? A multilevel longitudinal study of 261,669 Australians aged 45 years and older tracked over 11 years.

Cross-sectional studies of Alzheimer's disease tend to report higher risk in 'rural' areas. Multilevel longitudinal analysis of 261,669 participants in the Sax Institute's 45 and Up Study was conducte...

An updated Alzheimer hypothesis: Complement C3 and risk of Alzheimer's disease-A cohort study of 95,442 individuals.

We tested the hypothesis that low plasma complement C3 is observationally and genetically associated with high risk of Alzheimer's disease.

The National Institute on Aging-Alzheimer's Association Framework on Alzheimer's disease: Application to clinical trials.

The National Institute on Aging-Alzheimer's Association Research Framework on Alzheimer's disease (AD) represents an important advance in the biological characterization of the AD spectrum.

Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease.

The tau protein plays a central role in Alzheimer's disease (AD), and there is huge interest in measuring tau in blood and cerebrospinal fluid (CSF).

Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology.

The level of the presynaptic protein growth-associated protein 43 (GAP-43) in cerebrospinal fluid (CSF) has previously been shown to be increased in Alzheimer's disease (AD) and thus may serve as an o...

Clinical Trials [1285 Associated Clinical Trials listed on BioPortfolio]

Combining a Caregiver Intervention With Aricept Treatment for Mild to Moderate Alzheimer’s Disease

A unique multinational study was conducted simultaneously in the USA, England and Australia. The goals of the study were to answer two questions: Does psychosocial support for the family e...

Ascending Dose Study of CT1812 in Mild to Moderate Alzheimer's Disease

This is a multi-center, randomized, double-blind, placebo-controlled, parallel group study of two doses of CT1812 in adults with mild to moderate Alzheimer's Disease to evaluate the safety...

Dominantly Inherited Alzheimer Network (DIAN)

The purpose of this study is to identify potential biomarkers that may predict the development of Alzheimer's disease in people who carry an Alzheimer's mutation.

Western Australian Pre-exposure Prophylaxis for HIV Implementation Trial

Despite all prevention efforts, many people in Australia continue to be infected with HIV. The Seventh National HIV Strategy 2014-2017 in Australia aims to work towards the elimination of ...

Alzheimer and Sleep

The aim of the study is the analysis of two inhibitors of Ach-E: galantamine and donépézil in over 65 years' old patients suffering from Alzheimer disease (MMSE between 20 and 26) withou...

Companies [730 Associated Companies listed on BioPortfolio]

Alzheimer’s Australia

Dr Tanya Petrovich, Business Development Manager, Alzheimer’s Australia Vic;

Alzheimer's Research Foundation

The Fisher Center for Alzheimer's Research Foundation is a leading source of funding for Alzheimer's research. It serves Alzheimer's patients and their families to understand the causes of Alzheimer'...

Alzheimer’s Greater Los Angeles

Alzheimer’s Greater Los Angeles (formerly known as Alzheimer’s Association, California Southland Chapter) provides programs and services free of charge to individuals wi...

The Alzheimer's Association

The Alzheimer's Association is the leading voluntary health organization in Alzheimer care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of resear...

Alzheimer’s Orange County

Alzheimer’s Orange County provides programs and services, free of charge, to Orange County residents with Alzheimer’s and related dementia disorders, their families, car...

More Information about "Alzheimer’s Australia" on BioPortfolio

We have published hundreds of Alzheimer’s Australia news stories on BioPortfolio along with dozens of Alzheimer’s Australia Clinical Trials and PubMed Articles about Alzheimer’s Australia for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alzheimer’s Australia Companies in our database. You can also find out about relevant Alzheimer’s Australia Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record